By Associate Professor Min Jun

Book Chapters

Jun M; Perkovic V, 2015, 'Fibrates: risk-benefits and role in treating dyslipidemias', in Dyslipidemias Pathophysiology, Evaluation and Management, Humana Press

Jun M; Perkovic V; Cass A, 2011, 'Intensive glycemic control and renal outcome', in Diabetes and the Kidney, Karger Medical and Scientific Publishers

Journal articles

Neuen BL; Ostrominski JW; Claggett B; Beldhuis IE; Chatur S; McCausland FR; Badve SV; Arnott C; Heerspink HJL; Jun M; Falster M; de Oliveira Costa J; Pollock C; Jardine MJ; Mahaffey KW; Perkovic V; Solomon SD; Vaduganathan M, 2024, 'Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes', Journal of the American College of Cardiology, 84, pp. 2246 - 2250, http://dx.doi.org/10.1016/j.jacc.2024.08.006

Cashmore B; Tunnicliffe DJ; Palmer S; Blythen L; Boag J; Kostner K; Krishnasamy R; Lambert K; Miller A; Mullan J; Patu M; Phoon RKS; Rix L; Trompf N; Johnson DW; Walker R; Lee V; Coolican H; Cullen V; Fortnum D; Hassan H; Jun M; Craig J; Light C; Nguyen T; Scuderi C; See E; Viecelli A; Walker R, 2024, 'Australian and New Zealand Living Guideline cholesterol-lowering therapy for people with chronic kidney disease (CARI Guidelines): Reducing the evidence-practice gap', Nephrology, 29, pp. 495 - 509, http://dx.doi.org/10.1111/nep.14295

Maeda T; Woodward M; Jun M; Sakamoto Y; Chen X; Matsushita K; Mancia G; Arima H; Anderson CS; Chalmers J; Harris K, 2024, 'Risk of recurrent stroke and dementia following acute stroke by changes in kidney function: results from the Perindopril Protection Against Recurrent Stroke Study', Journal of Hypertension, 42, pp. 1313 - 1321, http://dx.doi.org/10.1097/HJH.0000000000003711

Scholes-Robertson N; Guha C; Gutman T; Howell M; Yip A; Cashmore B; Roberts I; Lopez-Vargas P; Wong G; MacGinley R; Synnot A; Craig JC; Jauré A; Krishnasamy R; Tunnicliffe DJ; Lee V; Boag J; Coolican H; Cullen V; Fortnum D; Hassan H; Jun M; Lambert K; Light C; Nguyen T; Palmer S; Scuderi C; See E; Viecelli A; Walker R, 2024, 'Consumer involvement in the development and dissemination of chronic kidney disease guidelines: a summary of a meaningful and sustainable approach developed by Caring for Australians and New ZealandeRs with kidney Impairment guidelines', Journal of Clinical Epidemiology, 170, http://dx.doi.org/10.1016/j.jclinepi.2024.111330

Ha JT; Freedman SB; Kelly DM; Neuen BL; Perkovic V; Jun M; Badve SV, 2024, 'Kidney Function, Albuminuria, and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis', American Journal of Kidney Diseases, 83, pp. 350 - 359.e1, http://dx.doi.org/10.1053/j.ajkd.2023.07.023

Neuen BL; Jun M; Wick J; Kotwal S; Badve SV; Jardine MJ; Gallagher M; Chalmers J; Nallaiah K; Perkovic V; Peiris D; Rodgers A; Woodward M; Ronksley PE, 2024, 'Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data', The Lancet Regional Health - Western Pacific, 43, http://dx.doi.org/10.1016/j.lanwpc.2023.100988

Jun M; Wick J; Neuen BL; Kotwal S; Badve SV; Woodward M; Chalmers J; Peiris D; Rodgers A; Nallaiah K; Jardine MJ; Perkovic V; Gallagher M; Ronksley PE, 2024, 'The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset', Kidney International Reports, 9, pp. 312 - 322, http://dx.doi.org/10.1016/j.ekir.2023.11.022

Milder TY; Lin J; Pearson SA; de Oliveira Costa J; Neuen BL; Pollock C; Jun M; Greenfield JR; Day RO; Stocker SL; Brieger D; Falster MO, 2024, 'Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?', Diabetes, Obesity and Metabolism, http://dx.doi.org/10.1111/dom.16061

Ketema DB; Wallace H; Neuen BL; Kotwal SS; Ronksley PE; Badve S; Perkovic V; Gallagher MP; Joshi R; Jun M, 2024, 'Assessing the Quality of Care for People with CKD: A Systematic Review and Meta-Analysis', Journal of the American Society of Nephrology, 35, http://dx.doi.org/10.1681/asn.2024bzcfkb63

Siriwardana A; Jardine M; Perkovic V; Jun M; Kotwal SS; Arnott CG; Neuen BL, 2024, 'Cardiovascular, Kidney, and Safety Outcomes with Canagliflozin in Older Adults: A Pooled Secondary Analysis of the CANVAS Program and CREDENCE Trial', Journal of the American Society of Nephrology, 35, http://dx.doi.org/10.1681/asn.2024e59ygyz9

Ha JT; Hiremath S; Jun M; Green SC; Wheeler DC; Coyne DW; Perkovic V; Badve SV, 2024, 'Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease.', NEJM Evid, 3, pp. EVIDoa2300189, http://dx.doi.org/10.1056/EVIDoa2300189

Yeung EK; Ferguson TW; Tangri N; Vaduganathan M; Arnott CG; Jun M; Kotwal SS; Jardine M; Perkovic V; Heerspink HJL; Neuen BL, 2024, 'Risk-Based Implementation of SGLT2 Inhibitors: Insights from the CANVAS Program and CREDENCE Trial', Journal of the American Society of Nephrology, 35, http://dx.doi.org/10.1681/asn.2024k6fn2ax5

Wallace H; Wick J; Ketema DB; Neuen BL; Jardine M; Lin J; Nelson CL; Pearson S; Peiris D; Woodward M; Ronksley PE; Gallagher MP; Kotwal SS; Jun M, 2024, 'Use of SGLT2 Inhibitors and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in Australian Primary Care Patients with Type 2 Diabetes Mellitus (T2DM) Stratified by CKD Status', Journal of the American Society of Nephrology, 35, pp. 10.1681/asn.2024f7q40fk1, http://dx.doi.org/10.1681/asn.2024f7q40fk1

Ha J; Hiremath S; Jun M; Palmer S; Wheeler D; Coyne D; Perkovic V; Badve S, 2024, 'WCN24-2313 LONG-TERM SAFETY OF HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITORS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS', Kidney International Reports, 9, pp. S562 - S563, http://dx.doi.org/10.1016/j.ekir.2024.02.1183

Colombijn JMT; Hooft L; Jun M; Webster AC; Bots ML; Verhaar MC; Vernooij RWM, 2023, 'Antioxidants for adults with chronic kidney disease', Cochrane Database of Systematic Reviews, 2023, http://dx.doi.org/10.1002/14651858.CD008176.pub3

Young TK; Hockham C; Sukkar L; Kang A; Jun M; Foote C; Baker J; Rogers K; Zoungas S; Cass A; Sullivan D; Jardine MJ, 2023, 'Duration and effectiveness of glucose-lowering regimens in the real world management of diabetes: Data from the Australian EXTEND45 Linked Cohort Study', Endocrine and Metabolic Science, 12, http://dx.doi.org/10.1016/j.endmts.2023.100135

Jun M; Scaria A; Andrade J; Badve SV; Birks P; Bota SE; Campain A; Djurdjev O; Garg AX; Ha J; Harel Z; Hemmelgarn B; Hockham C; James MT; Jardine MJ; Levin A; Mcarthur E; Ravani P; Shao S; Sood MM; Tan Z; Tangri N; Whitlock R; Gallagher M, 2023, 'Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study', European Heart Journal - Quality of Care and Clinical Outcomes, 9, pp. 621 - 631, http://dx.doi.org/10.1093/ehjqcco/qcac069

Pettigrew S; Santos JA; Li Y; Jun M; Anderson C; Jones A, 2023, 'Short report: Factors contributing to young people's susceptibility to e-cigarettes in four countries', Drug and Alcohol Dependence, 250, http://dx.doi.org/10.1016/j.drugalcdep.2023.109944

Fletcher RA; Arnott C; Rockenschaub P; Schutte AE; Carpenter L; Vaduganathan M; Agarwal R; Bakris G; Chang TI; Heerspink HJL; Jardine MJ; Mahaffey KW; Neal B; Pollock C; Jun M; Rodgers A; Perkovic V; Neuen BL, 2023, 'Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials', Journal of the American Heart Association, 12, pp. e028516, http://dx.doi.org/10.1161/JAHA.122.028516

Ha JT; Scaria A; Andrade J; Badve SV; Birks P; Bota SE; Campain A; Djurdjev O; Garg AX; Harel Z; Hemmelgarn B; Hockham C; James MT; Jardine MJ; Lam D; Levin A; McArthur E; Ravani P; Shao S; Sood MM; Tan Z; Tangri N; Whitlock R; Gallagher M; Jun M, 2023, 'Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada', Kidney Medicine, 5, http://dx.doi.org/10.1016/j.xkme.2023.100675

Harris K; Muntner P; Woodward M; Jun M; Oshima M; Gong J; Harrap S; Menard J; Chalmers J, 2023, 'Clinical outcomes by atherosclerotic cardiovascular disease risk score and blood pressure level in high risk individuals with type 2 diabetes', Journal of Human Hypertension, 37, pp. 181 - 188, http://dx.doi.org/10.1038/s41371-022-00661-5

Pettigrew S; Alvin Santos J; Miller M; Sudhir Raj T; Jun M; Morelli G; Jones A, 2023, 'E-cigarettes: A continuing public health challenge in India despite comprehensive bans', Preventive Medicine Reports, 31, http://dx.doi.org/10.1016/j.pmedr.2022.102108

Feng Y; Wang AY; Jun M; Pu L; Weisbord SD; Bellomo R; Hong D; Gallagher M, 2023, 'Characterization of Risk Prediction Models for Acute Kidney Injury A Systematic Review and Meta-analysis', JAMA Network Open, 6, http://dx.doi.org/10.1001/jamanetworkopen.2023.13359

Talbot B; Cass A; Walker R; Hooi L; Jardine M; Jun M; Rogers K; Sukkar L; Smyth B; Gallagher M, 2023, 'Comparing survival in patients with chronic kidney disease across three countries – Results from the study of heart and renal protection-extended review', Nephrology, 28, pp. 36 - 43, http://dx.doi.org/10.1111/nep.14127

Ha J; Hiremath S; Jun M; Palmer S; Wheeler DC; Coyne DW; Perkovic V; Badve S, 2023, 'Long-Term Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in CKD: A Systematic Review and Meta-Analysis of Randomized Trials', Journal of the American Society of Nephrology, 34, pp. 367 - 367, http://dx.doi.org/10.1681/asn.20233411s1367a

Jun M; Wick J; Neuen BL; Kotwal SS; Badve S; Chalmers JP; Jardine M; Perkovic V; Gallagher MP; Ronksley PE, 2023, 'The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset', Journal of the American Society of Nephrology, 34, pp. 373 - 373, http://dx.doi.org/10.1681/asn.20233411s1373a

KIM D; Lee J; Toyama T; Liyanage T; Woodward M; Matsushita K; Hooi LS; Lin MY; Iseki K; Jha V; Wong MG; Jun M, 2023, 'WCN23-0200 PREVALENCE AND TREATMENT PATTERNS OF ANAEMIA IN INDIVIDUALS WITH CHRONIC KIDNEY DISEASE ACROSS ASIA', Kidney International Reports, 8, pp. S135 - S136, http://dx.doi.org/10.1016/j.ekir.2023.02.309

Pettigrew S; Miller M; Santos JA; Brown K; Morelli G; Sudhir T; Jun M; Jones A, 2022, 'Young people's support for various forms of e-cigarette regulation in Australia and the UK', International Journal of Drug Policy, 110, http://dx.doi.org/10.1016/j.drugpo.2022.103858

Pettigrew S; Miller M; Kannan A; Raj TS; Jun M; Jones A, 2022, 'School staff perceptions of the nature and consequences of students’ use of e-cigarettes', Australian and New Zealand Journal of Public Health, 46, pp. 676 - 681, http://dx.doi.org/10.1111/1753-6405.13281

Lambert K; Bahceci S; Harrison H; Chan M; Scholes-Robertson N; Johnson DW; Yip A; Viecelli AK; Krishnasamy R; Boag J; Coolican H; Craig J; Jun M; Lee V; Nguyen T; Scuderi C; See E; Walker R; Fortnum D; Cullen V; Howell M; Guha C; Tunnicliffe D; Johnston B, 2022, 'Commentary on the 2020 update of the KDOQI clinical practice guideline for nutrition in chronic kidney disease', Nephrology, 27, pp. 537 - 540, http://dx.doi.org/10.1111/nep.14025

Hockham C; Bao L; Tiku A; Badve SV; Bello AK; Jardine MJ; Jha V; Toyama T; Woodward M; Jun M, 2022, 'Sex differences in chronic kidney disease prevalence in Asia: A systematic review and meta-analysis', Clinical Kidney Journal, 15, pp. 1144 - 1151, http://dx.doi.org/10.1093/ckj/sfac030

Kang A; Sukkar L; Hockham C; Jun M; Young T; Scaria A; Foote C; Neuen BL; Cass A; Pollock C; Comino E; Lung T; Pecoits-Filho R; Rogers K; Jardine MJ; Chow C; Gallagher M; Jan S; Knight J; Liu B; McNamara M; Peiris D; Ssullivan D; Wong G; Zoungas S; Wilson R, 2022, 'Risk factors for incident kidney disease in older adults: an Australian prospective population-based study', Internal Medicine Journal, 52, pp. 808 - 817, http://dx.doi.org/10.1111/imj.15074

Campain A; Hockham C; Sukkar L; Rogers K; Chow CK; Lung T; Jun M; Pollock C; Cass A; Sullivan D; Comino E; Peiris D; Jardine M, 2022, 'Prior Cardiovascular Treatments—A Key Characteristic in Determining Medication Adherence After an Acute Myocardial Infarction', Frontiers in Pharmacology, 13, http://dx.doi.org/10.3389/fphar.2022.834898

Daniels B; Schaffer A; Buckley NA; Bruno C; Jun M; Pearson SA; Zoega H, 2022, 'The impact of tightened prescribing restrictions on proton pump inhibitor use in Australia: An evaluation using interrupted time series analysis', Pharmacoepidemiology and Drug Safety, 31, pp. 370 - 378, http://dx.doi.org/10.1002/pds.5395

Chidwick K; Myton R; Rodgers A; Jun M; Dartnell J; Balcomb A; Dore G, 2022, 'A cluster randomized controlled trial of a MedicineInsight Educational Quality Improvement Programme to improve the diagnosis and treatment of chronic hepatitis C in general practice (the EQUIP-HEPC trial)', Journal of Viral Hepatitis, 29, pp. 135 - 146, http://dx.doi.org/10.1111/jvh.13629

Liyanage T; Toyama T; Hockham C; Ninomiya T; Perkovic V; Woodward M; Fukagawa M; Matsushita K; Praditpornsilpa K; Hooi LS; Iseki K; Lin MY; Stirnadel-Farrant HA; Jha V; Jun M, 2022, 'Prevalence of chronic kidney disease in Asia: A systematic review and analysis', BMJ Global Health, 7, pp. e007525, http://dx.doi.org/10.1136/bmjgh-2021-007525

Fletcher RA; Arnott C; Rockenschaub P; Schutte AE; Carpenter L; Vaduganathan M; Heerspink HJ; Neal B; Jun M; Rodgers A; Perkovic V; Neuen B, 2022, 'Abstract P201: Canagliflozin, Visit-to-visit Blood Pressure Variability, And Risk Of Cardiovascular, Kidney, And Mortality Outcomes: Pooled Individual Participant Data From The CANVAS And CREDENCE Trials', Hypertension, 79, http://dx.doi.org/10.1161/hyp.79.suppl_1.p201

Ha J; Freedman B; Kelly DM; Neuen BL; Perkovic V; Jun M; Badve S, 2022, 'Lower Glomerular Filtration Rate and Higher Albuminuria Are Associated With Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis', Journal of the American Society of Nephrology, 33, pp. 297 - 298, http://dx.doi.org/10.1681/asn.20223311s1297c

Harel Z; McArthur E; Jeyakumar N; Sood MM; Garg AX; Silver SA; Dorian P; Blum D; Beaubien-Souligny W; Yan AT; Badve SV; Smyth B; Jun M; Jandoc R; Kitchlu A; Wald R, 2021, 'The risk of acute kidney injury with oral anticoagulants in elderly adults with atrial fibrillation', Clinical Journal of the American Society of Nephrology, 16, pp. 1470 - 1479, http://dx.doi.org/10.2215/CJN.05920421

Pettigrew S; Jun M; Roberts I; Nallaiah K; Rodgers A, 2021, 'The Potential Effectiveness of COVID-Related Smoking Cessation Messages in Three Countries', Nicotine and Tobacco Research, 23, pp. 1254 - 1258, http://dx.doi.org/10.1093/ntr/ntab023

Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Matteau A; Paterson JM; Quail J; Renoux C, 2021, 'Effectiveness and safety among direct oral anticoagulants in nonvalvular atrial fibrillation: A multi-database cohort study with meta-analysis', British Journal of Clinical Pharmacology, 87, pp. 2589 - 2601, http://dx.doi.org/10.1111/bcp.14669

Jun M; Harris K; Heerspink HJL; Badve SV; Jardine MJ; Harrap S; Hamet P; Marre M; Poulter N; Kotwal S; Gallagher M; Perkovic V; Chalmers J; Woodward M, 2021, 'Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial', Diabetes, Obesity and Metabolism, 23, pp. 1420 - 1425, http://dx.doi.org/10.1111/dom.14351

Nataatmadja M; Krishnasamy R; Zuo L; Hong D; Smyth B; Jun M; de Zoysa JR; Howard K; Wang J; Lu C; Liu Z; Chan CT; Cass A; Perkovic V; Jardine M; Gray NA, 2021, 'Quality of Life in Caregivers of Patients Randomized to Standard- Versus Extended-Hours Hemodialysis', Kidney International Reports, 6, pp. 1058 - 1065, http://dx.doi.org/10.1016/j.ekir.2021.01.020

O'Hara DV; Parkhill TR; Badve SV; Jun M; Jardine MJ; Perkovic V, 2021, 'The effects of dipeptidyl peptidase-4 inhibitors on kidney outcomes', Diabetes, Obesity and Metabolism, 23, pp. 763 - 773, http://dx.doi.org/10.1111/dom.14281

Palagyi A; Balane C; Shanthosh J; Jun M; Bhoo-Pathy N; Gadsden T; Canfell K; Jan S, 2021, 'Treatment abandonment in children with cancer: Does a sex difference exist? A systematic review and meta-analysis of evidence from low- and middle-income countries', International Journal of Cancer, 148, pp. 895 - 904, http://dx.doi.org/10.1002/ijc.33279

Oshima M; Hara A; Toyama T; Jun M; Pollock C; Jardine M; Harrap S; Poulter N; Cooper ME; Woodward M; Chalmers J; Perkovic V; Wong MG; Wada T, 2021, 'Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor', Kidney International Reports, 6, pp. 284 - 295, http://dx.doi.org/10.1016/j.ekir.2020.10.039

Neuen BL; Arnott C; Perkovic V; Figtree G; de Zeeuw D; Fulcher G; Jun M; Jardine MJ; Zoungas S; Pollock C; Mahaffey KW; Neal B; Heerspink HJL, 2021, 'Sodium-glucose co-transporter-2 inhibitors with and without metformin: A meta-analysis of cardiovascular, kidney and mortality outcomes', Diabetes, Obesity and Metabolism, 23, pp. 382 - 390, http://dx.doi.org/10.1111/dom.14226

Riaz P; Caskey F; McIsaac M; Davids R; Htay H; Jha V; Jindal K; Jun M; Khan M; Levin A; Lunney M; Okpechi I; Pecoits-Filho R; Osman MA; Vachharajani T; Ye F; Harris D; Tonelli M; Johnson D; Bello A, 2021, 'Workforce capacity for the care of patients with kidney failure across world countries and regions', BMJ Global Health, 6, http://dx.doi.org/10.1136/bmjgh-2020-004014

Back to profile page